Cytochrome P450-2E1 is involved in aging-related kidney damage in mice through increased nitroxidative stress

Mohamed A Abdelmegeed1, Youngshim Choi1, Seung-Kwoon Ha1

  • 1Section of Molecular Pharmacology and Toxicology, Laboratory of Membrane Biochemistry and Biophysics, National Institute on Alcohol Abuse and Alcoholism, Bethesda, MD, USA.

Insights

Cytochrome P450-2E1 (CYP2E1) contributes to kidney damage in aging, likely by increasing oxidative stress. Eliminating CYP2E1 may protect against age-related kidney disease.

Area of Science:

  • Biochemistry
  • Gerontology
  • Nephrology

Background:

  • Aging is associated with kidney damage, but the underlying mechanisms are not fully understood.
  • Cytochrome P450-2E1 (CYP2E1) is implicated in cellular damage, but its role in aging-dependent kidney dysfunction requires investigation.

Purpose of the Study:

  • To investigate the role of CYP2E1 in aging-related kidney damage.
  • To determine if CYP2E1 contributes to oxidative stress and kidney dysfunction in aged mice.

Main Methods:

  • Comparison of kidney histology, oxidative stress markers (hydrogen peroxide, protein carbonylation, nitration), inflammatory markers (TNF-α), and kidney function (serum creatinine) in young and aged wild-type (WT) and Cyp2e1-null mice.
  • Assessment of mitochondrial function and antioxidant capacity, including glutathione (GSH) levels and specific enzyme activities.

Main Results:

  • Aged WT mice showed significant kidney aging signs, elevated TNF-α and creatinine, increased oxidative and nitroxidative stress markers, and reduced GSH compared to other groups.
  • Aged Cyp2e1-null mice exhibited enhanced antioxidant capacity (heme oxygenase-1, catalase), normal GSH levels, and reduced mitochondrial nitroxidative stress compared to aged WT mice.

Conclusions:

  • CYP2E1 plays a critical role in promoting aging-related kidney damage, primarily through the exacerbation of nitroxidative stress.
  • CYP2E1 inhibition represents a potential therapeutic target for preventing or mitigating age-related kidney diseases.

Related Concept Videos

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism

Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
249
Bioactivation and Tissue Toxicity01:25

Bioactivation and Tissue Toxicity

Bioactivation is a metabolic process that transforms less reactive substances into highly reactive metabolites, initiating tissue toxicity. This transformation can lead to various toxic effects, including carcinogenesis and teratogenesis. Reactive metabolites are classified into two main types: electrophiles and free radicals.Electrophiles are electron-deficient species and are produced primarily by the enzyme cytochrome P-450 during the metabolism of compounds containing carbon, nitrogen, or...
38
Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
19.2K
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion

In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
274
Mitochondria01:37

Mitochondria

Mitochondria are eukaryotic cellular organelles that are known to produce energy through a process called oxidative phosphorylation. Besides their primary function, mitochondria are involved in various cellular processes, including cell growth, differentiation, signaling, metabolism, and senescence. Age-related changes cause a decline in mitochondrial quality and integrity due to increased mitochondrial mutations and oxidative damage. Thus, aging can severely impact mitochondrial functions,...
21.0K
Aging01:26

Aging

Aging is a complex biological phenomenon influenced by various processes that affect cellular and systemic functions. Several prominent theories attempt to explain its mechanisms, highlighting cellular limitations, oxidative damage, and hormonal changes as central factors in aging.
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
889